Cpharm wants to build hash processing plant in Afghanistan
Yesterday, officials from the Interior Ministry’s Drug Control Department met with a representative of the company (Cpharm).
The company wants to build a cannabis processing plant in Afghanistan, where all cannabis products will be made.
“The company wants to build a cannabis processing plant in Afghanistan that will make all cannabis products,” Khosty said in a tweet.
“The company plans to invest $430 million in this sector. This project will officially start in the coming days.”
Cpharm, a small company based in Maitland, NSW, has since been inundated with requests for comment and was forced on Thursday to clarify that it had nothing to do with the Taliban or the apparent deal.
“No one from here has met anyone. It has nothing to do with us,” Cpharm director Josie Gabites told SBS News.
“We have nothing to do with the Taliban or cannabis. And we have no idea where this is coming from.
“There is no connection between us and the Taliban or cannabis.”
The company said it was not a manufacturer or supplier of products but provided medical advice to the pharmaceutical industry in Australia.
“We don’t have hemp. We have no product, we produce nothing,” said Ms. Gabites.
“We provide advice to pharmaceutical companies. We have no products, we do not manufacture, we do not distribute.”
Australia has a Taliban sanctions regime that restricts the provision of assets to “designated persons or entities”.
SBS News has contacted Mr Khosty for clarification.